United States · Platforms & data · MarketBeat
PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock
PTC Therapeutics (NASDAQ:PTCT - Get Free Report) announced that its Board of Directors has approved a stock buyback program on Tuesday, November 3rd, RTT News reports. The company…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)
